Industry-Sponsored Research Week
[promoslider width="728px" height="90px" category="tech-transfer-enews-header-banner"]

Yale snags sponsored research deal with CYduct Diagnostics


By David Schwartz
Published: April 13th, 2021

Yale University has entered into a Sponsored Research Agreement CYduct Diagnostics, Inc., to test and evaluate the performance of the university’s nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of breast cancer. The one-year agreement also grants CYduct an exclusive option for an exclusive worldwide license in the field of use to the underlying nanowire intellectual property, including any inventions made during the research process.

The assessment involves the CMOS nanowire biosensor technology invented by Mark A. Reed PhD, associate director of the Yale Institute for Nanoscience and Quantum Engineering. They attempt to determine the utility of the technology for assessing overall breast health, the risk of future breast cancer, and/or the presence of metabolic biomarkers indicative of breast cancer.

“This is an exciting application for Yale’s innovative nanowire sensor technology that could have a vital impact on the future of women’s healthcare,” stated Chris Sutton PhD, CYduct Diagnostics chief science officer.

“All women, but especially those with dense breast tissue, are an embattled cohort who could significantly benefit from this progressive risk-screening technology,” added the company CEO Dominick Gatto. “I am pleased that Yale University acknowledges the value in additional molecular diagnostic information provided by their nanowire biosensor, which will aid women and their physicians in determining the risk of breast disease on a personal medicine basis.”

Financial terms of the Agreement were not disclosed.

Source: BioSpace

Posted under: University-Industry Engagement Week

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment